U
CPAH

UBS’s Counterpath Corp CPAH Stock Holding History

UBS’s Portfolio CPAH Stock Details CPAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-65
Closed -$1K – 11175
2014
Q2 		$1K Sell
65
-385
-86% -$4.74K ﹤0.01% 10313
2014
Q1 		$7K Buy
450
+191
+74% +$2.29K ﹤0.01% 9312
2013
Q4 		$3K Buy
+259
New +$3.39K ﹤0.01% 9949

Other funds holding CPAH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

UBS's CPAH Position: Q3 2014 in Review

UBS sold out of Counterpath Corp (CPAH) in Q3 2014, closing a stake of 65 shares — an estimated $1K sold.

UBS first reported a position in CPAH in Q4 2013 and held it in 3 quarters. The position peaked at $7K in Q1 2014. 7 funds tracked by Wall St. Rank hold CPAH as of Q3 2014.

  • UBS reported no remaining Counterpath Corp position as of Q3 2014 after selling out during the quarter.
  • UBS sold 65 Counterpath Corp shares in Q3 2014, an estimated $1K.
  • UBS first reported a position in Counterpath Corp in Q4 2013 and held it in 3 quarters.
  • UBS's Counterpath Corp position peaked at $7K in Q1 2014.
  • 7 funds tracked by Wall St. Rank held Counterpath Corp as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.